Wright Medical steps forward with knee licence:
This article was originally published in Clinica
Executive Summary
Wright Medical is to license a total knee prosthesis, the 913 knee, developed by the New York Hospital for Special Surgery. According to Wright chairman and CEO Herbert Korthoff: "This agreement will give us a substantial head start in developing a new prosthesis involving the sacrifice of the posterior cruciate ligament. This surgical technique is the most rapidly growing part of the total knee replacement market."